Filtered By:
Condition: Diabetes Type 2
Countries: Sweden Health
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 104 results found since Jan 2013.
Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study
World Psychiatry. 2022 Oct;21(3):452-459. doi: 10.1002/wps.21020.ABSTRACTAccumulating evidence suggests a higher risk for cardiovascular diseases among individuals with mental disorders, but very little is known about the risk for overall and specific groups of cardiovascular diseases in people with attention-deficit/hyperactivity disorder (ADHD). To fill this knowledge gap, we investigated the prospective associations between ADHD and a wide range of cardiovascular diseases in adults. In a nationwide population-based cohort study, we identified 5,389,519 adults born between 1941 and 1983, without pre-existing cardiovascul...
Source: World Psychiatry - September 8, 2022 Category: Psychiatry Authors: Lin Li Zheng Chang Jiangwei Sun Miguel Garcia-Argibay Ebba Du Rietz Maja Dobrosavljevic Isabell Brikell Tomas Jernberg Marco Solmi Samuele Cortese Henrik Larsson Source Type: research
High Blood Pressure and Diabetes Are Linked. Here ’ s How to Reduce Your Risk for Both
High blood pressure—also known as hypertension—and Type 2 diabetes are two of the most common medical conditions in the U.S. Unfortunately, they often occur together. Some research has found that 85% of middle-aged or older adults who have Type 2 diabetes also have hypertension, and both conditions elevate a person’s risk for heart disease, stroke, and kidney disease.
These increased risks are significant, and in some cases grave. Researchers have found that people with Type 2 diabetes are up to four times more likely to develop cardiovascular disease than those who don’t have the conditio...
Source: TIME: Health - August 29, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Diabetes, heart disease in combination create higher dementia risk, study shows
Dementia risk doubles if a person has at least two of these three diseases: type 2 diabetes, stroke or heart disease, according to Swedish research published Thursday.
Source: Health News - UPI.com - June 16, 2022 Category: Consumer Health News Source Type: news
Estimating Insulin Resistance May Help Predict Stroke, Death in T2D Estimating Insulin Resistance May Help Predict Stroke, Death in T2D
Calculating the estimated glucose disposal rate as a proxy for the level of insulin resistance may be useful way to determine if someone with type 2 diabetes is at risk for having a first stroke, Swedish researchers have found.Medscape Medical News
Source: Medscape Medical News Headlines - October 21, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Circulating TNFrII levels predict incidence of ischemic heart disease and total mortality, independently of intima media thickness and pulse wave velocity in male with type 2 diabetes
AbstractNew and clinically useful markers of cardiovascular risk are of great importance in patients with type 2 diabetes since cardiovascular disease is a major cause of death in these patients. We analyzed inflammatory markers and other risk factors for heart disease in 761 patients who participated in the CARDIPP-study, Cardiovascular Risk factors in Patients with Diabetes —a Prospective study in Primary care. All participants had type 2 diabetes and were 55–66 years old at recruitment during the years 2005–2008. Patients were followed for incidence of stroke, myocardial infarction, or death from cardiovascular d...
Source: Heart and Vessels - August 21, 2021 Category: Cardiology Source Type: research
Vascular ultrasound for cardiovascular risk stratification in asymptomatic patients with type-2 diabetes
CONCLUSION: Duplex ultrasonography to screen for atherosclerotic plaques improve the estimation of cardiovascular prognosis on top of clinical data and could be routinely used to improve cardiovascular risk stratification.PMID:33896756 | DOI:10.1016/j.pcd.2021.04.006
Source: Primary Care - April 26, 2021 Category: Primary Care Authors: Angeladine Kenne Malaha Julien Magne Lucile Jarlan Katia Mansour Melissa Ait-Ouatet Sophie Galinat Marie-Pierre Teissier Philippe Lacroix Ileana Desormais Victor Aboyans Source Type: research
Use of sodium –glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry
ConclusionIn a contemporary HF cohort with T2DM, SGLT2i use increased over time, was more common with specialist care, younger age, ischaemic heart disease, and preserved renal function, and was associated with lower mortality and morbidity.
Source: European Journal of Heart Failure - March 3, 2021 Category: Cardiology Authors: Peter M. Becher,
Benedikt Schrage,
Giulia Ferrannini,
Lina Benson,
Javed Butler,
Juan Jesus Carrero,
Francesco Cosentino,
Ulf Dahlstr öm,
Linda Mellbin,
Giuseppe M.C. Rosano,
Gianfranco Sinagra,
Davide Stolfo,
Lars H. Lund,
Gianluigi Savares Tags: Research Article Source Type: research
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
Conclusions/interpretationThe economic burden of complications in type 2 diabetes is substantial. Costs of absence from work in this study were found to be greater than of hospital-based care, highlighting the need for considering treatment consequences in a societal perspective in research and policy.Graphical abstract
Source: Diabetologia - November 4, 2020 Category: Endocrinology Source Type: research
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection
Cardiovascular (CV) disease prevention in type 2 diabetes (T2D) demands multifactorial interventions including treatment of dyslipidemia, hypertension, hypercoagulability, and certainly hyperglycemia [1]. However, randomized controlled trials specifically addressing the impact of intensive glucose control (IGC) on CV outcomes yielded ambiguous results [2], while real-life evidence from a Swedish nationwide registry showed hyperglycemia as the strongest predictor of myocardial infarction (MI) and stroke [3].
Source: Metabolism - Clinical and Experimental - May 25, 2020 Category: Biomedical Science Authors: Irene Caruso, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino Tags: Commentaries Source Type: research
Medical News Today: Higher risk of stroke can follow midlife type 2 diabetes
A study of twins in Sweden links a 30% higher risk in older age of brain artery blockage, which stroke often follows, to type 2 diabetes in middle age.
Source: Health News from Medical News Today - June 12, 2019 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news
Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
ConclusionThe prevalence of CVD in patients with type 2 diabetes in clinical practice in Sweden was 28.3% during the study period, and it was 11.5% in the patients starting empagliflozin treatment. Patients of the latter cohort were, however, younger, more obese, and more likely to have unsatisfactory glycemic control, requiring additional treatment. Overall, a large proportion of type 2 diabetes patients should be considered at high cardiovascular risk.FundingBoehringer Ingelheim AB, Sweden.
Source: Diabetes Therapy - May 13, 2019 Category: Endocrinology Source Type: research
